MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 38 filers reported holding MILESTONE PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $66,294 | -34.2% | 23,261 | -9.1% | 0.00% | – |
| Q1 2023 | $100,809 | -71.3% | 25,586 | -71.2% | 0.00% | – |
| Q4 2022 | $351,252 | -89.3% | 88,700 | -75.1% | 0.00% | -100.0% |
| Q3 2022 | $3,278,000 | +1862.9% | 356,708 | +1163.4% | 0.00% | – |
| Q2 2022 | $167,000 | +135.2% | 28,233 | +154.4% | 0.00% | – |
| Q1 2022 | $71,000 | -64.1% | 11,100 | -67.9% | 0.00% | – |
| Q3 2021 | $198,000 | -65.8% | 34,600 | -67.1% | 0.00% | – |
| Q2 2021 | $579,000 | +8.0% | 105,200 | +13.6% | 0.00% | – |
| Q1 2021 | $536,000 | +294.1% | 92,600 | +356.4% | 0.00% | – |
| Q4 2020 | $136,000 | – | 20,288 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alta Fundamental Advisers LLC | 1,176,189 | $3,646,186 | 1.74% |
| Bleichroeder LP | 1,326,085 | $4,110,864 | 1.01% |
| BML Capital Management, LLC | 272,500 | $844,750 | 0.78% |
| VR Adviser, LLC | 2,208,812 | $6,847,317 | 0.72% |
| Lion Point Capital, LP | 450,207 | $1,395,642 | 0.62% |
| PVG ASSET MANAGEMENT CORP | 15,405 | $47,755 | 0.32% |
| Affinity Asset Advisors, LLC | 335,068 | $1,038,711 | 0.29% |
| RTW INVESTMENTS, LP | 3,256,102 | $10,093,916 | 0.21% |
| Ikarian Capital, LLC | 462,828 | $1,434,767 | 0.17% |
| Boxer Capital, LLC | 309,007 | $957,922 | 0.05% |